| CEO Name | Herve Hoppenot |
| Nationality | France |
| Net Worth Estimation | $100 million |
Herve Hoppenot's estimated net worth of around $100 million primarily derives from his long tenure as CEO of Incyte Corporation, substantial equity holdings, stock options, and annual compensation packages. Public records show significant Incyte share ownership and executive earnings contribute heavily to this valuation.
Herve Hoppenot, CEO of Incyte Corporation, has an estimated net worth of $100 million, exceeding the industry's maximum range of $90 million by about 11%. This positions his net worth at least 11% higher than the typical maximum for healthcare CEOs.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Herve Hoppenot Performance in Incyte Corporation
Herve Hoppenot, CEO of Incyte Corporation, demonstrates strong leadership by driving innovative strategies and fostering a collaborative corporate culture. His decisive approach to resource allocation and pipeline prioritization has accelerated drug development and expanded market presence. Under Hoppenot's tenure, Incyte has seen significant revenue growth and enhanced its status as a leader in oncology and inflammation therapeutics.
Latest News
Incyte Corporation Appoints Bill Meury as New CEO Amid Leadership Transition
Incyte, a leading biopharmaceutical company, has named industry veteran Bill Meury as its new CEO, replacing Herve Hoppenot after 11 years of leadership; Hoppenot will remain on the board through 2025 to ensure a smooth transition.
Source: http://www.biopharmadive.com/news/incyte-ceo-replace-herve-hoppenot-bill-meury/751727/